Form 4 for ENTA ENANTA PHARMACEUTICALS INC
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001062993-23-021981 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-05 | 2023-12-01 | ENTA | Luly Jay R. | Pres, CEO, Dir | F - Tax | $9.49 | -5,787 | 814.0K | -0.7% | -$54.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | F | D | 5,787 | $9.49 | 814,023 | D | — | — | (F1) Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit awards granted on November 20, 2020 and November 19, 2021. |